Professor Mariana Mazzucato, Professor in Economics at the University of Sussex, Joins The Innovation Debate 2012, The Royal

   Professor Mariana Mazzucato, Professor in Economics at the University of
  Sussex, Joins The Innovation Debate 2012, The Royal Society, 20th November

  PR Newswire

  CHERTSY, England, November 15, 2012

CHERTSY, England, November 15, 2012 /PRNewswire/ --

  To watch the debate live register FREE today at

PROFESSORMARIANA MAZZUCATO , Professor in Economics at the University of
Sussex, where she holds the RM Phillips Chair in Science and Technology
Policy, will join the distinguished panel of world-leading experts and
chairman Professor Jim Al-Khalili for The Innovation Debate 2012 , taking
place on 20 ^th November at 4pm at the Royal Society in London and webcast
live at .


Together they will debate "How do we innovate in a time austerity?" and "Are
we doing enough to nurture innovators of the future?"

Presenting her views on the current state of innovation, Professor Mazzucato -
who is a member of Innovation for Growth (i4g), the European Commission's High
Level Economic Policy Expert Group - said:

"If Europe is to move forward - not only getting out of the current recession,
but also providing the foundations for long-run transformational growth - it
needs a vision and mission oriented investments similar to those which in the
60s guided putting a 'man on the moon' and later the internet revolution,
which, along with much of Silicon Valley was largely funded by the State.

"The new vision should be 'green' - transforming the way all sectors operate -
and should be of scale and scope to compete with China's recently announced
plan to invest $1.7 trillion in seven new emerging areas. This requires a new
understanding of the State's role in the economy, getting over the static fear
of 'picking winners'. We must build an 'innovation union' through a real
coming together of the public and private sector, but also asking the private
sector to step up to the challenge, invest not in short run areas which boost
only today's stock price, but in long-run areas that will allow Europe to rise
again and turn into a competitive new hub of innovation-producing what will
hopefully be growth that is not only smart but also more 'inclusive' and

Professor Mazzucato - whose speciality is industrial economics and the
economics of growth - will join fellow-panellists who include: Professor Andre
Geim , awarded the Nobel Prize in 2010 for his ground-breaking work on
graphene, a one-atom-thick material made of carbon; Tudor Brown , former
President of Cambridge-based semiconductor giant ARM Holdings; Professor Paul
Workman , Deputy Chief Executive of the Institute of Cancer Research;
Professor Paul Boyle , President of Science Europe, which promotes the
collective interests of European research organisations and DRBeau Lotto ,
neuroscientist attached to University College, London's Institute of

In a tough economic climate, innovation needs to remain the lifeblood of
science, technology and the economy. There is an urgent need to focus on how
best to promote and nurture innovation - today and in the future.

That is why The Innovation Debate 2012 - organised and funded by Astellas
Pharma Europe Ltd . - is bringing together influential and respected figures
from the worlds of science, technology, medicine, education, government,
industry and the media to discuss how best to encourage and nurture scientific
innovation. The aim of The Innovation Debate is to air crucial issues, draw
positive conclusions and to move the agenda forward.

Everyone - professionals in science and technology, students and the general
public - will have the opportunity to engage with The Innovation Debate
through online media, taking discussions far beyond the walls of the Royal

Join the Innovation Debate 2012

The Innovation Debate will encourage wider participation from the public and
science community via the website . Everyone will
have the opportunity to share their views on the critical challenges facing
science and innovation raised by The Innovation Debate and to submit a
question to the panel of experts. To watch the live webcast of the Debate from
4pm on November 20 ^th 2012, register today at

Join the debate now at and follow us on Twitter
@Innovatedebate #innovationdebate

About Astellas Pharma Europe Ltd.

Astellas Pharma Europe Ltd., located in the UK, is the European headquarters
of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company
dedicated to improving the health of people around the world through the
provision of innovative and reliable pharmaceuticals. The organisation's focus
is to deliver outstanding R&D and marketing to continue growing in the world
pharmaceutical market. Astellas Pharma Europe Ltd. is responsible for 21
affiliate offices located across Europe, the Middle East and Africa, an R&D
site and three manufacturing plants. The company employs approximately 4,300
staff across these regions. For more information about Astellas Pharma Europe,
please visit .

Contact: For further information, please contact: Mindy Dooa, Communications
Director, Astellas Pharma Europe Ltd, Tel: +44-(0)203-379-8035, Mobile:
+44(0)7826-912-339, Email:
Press spacebar to pause and continue. Press esc to stop.